Education

1973–1975	University of Tennessee Knoxville, TN Ph.D. in Cellular Biology, dissertation in receptor biochemistry Mentor: Dr. Patricia B. Coulson/Shivers.
1969–1971	University of Denver Denver, CO M.S. in Cellular Biology, thesis in electron microscopy Mentors: Dr. Robert Angel & Dr. Ronald R. Cowden
1965–1969	University of Denver Denver, CO B.S. Mathematics & Chemistry, undergrad thesis in computer error Advisor: Dr. George Bardwell

 

Profile

Dr. Pavlik is a graduate of the University of Denver, and received his PhD from the University of Tennessee, Knoxville. He received a NCI Public Health Service Fellowship at the University of Illinois, Champaign-Urbana, Illinois and was a Visiting Assistant Professor, Department of Physiology and Biophysics at the University of Illinois, Champaign-Urbana. He is an active lecturer in the College of Medicine and organizes and mentors summer intern research including students from Denison University, Penn State University, Transylvania University, Centre

College, Vassar College, the University of North Carolina, Eastern Kentucky University, Depauw University, Union College and the University of Kentucky. He is a member of the Graduate College and serves on dissertation committees for the PhD degree. Dr. Pavlik is an author on over 100 peer reviewed publications, has presented at a number of prestigious international conferences, and has been funded by the NCI, the ACS and the VA. His research focus is on ovarian cancer screening and factors that affect screening accuracy and performance.

 

Research Interest

• Breast, Colorectal, Prostate, Cervical and Ovarian Cancer

Current Research Goals of the Screening Program

• To prospectively evaluate the false positive (FP) rate of the screening algorithm for distinguishing benign ovarian structures from ovarian malignancies.
• To assess the degree to which serial transvaginal ultrasonography identifies the fallopian tubes and changes in size and structure of the fallopian tubes.
• To assess the degree to which serial transvaginal ultrasonography revises a single ultrasound by comparisons of subsequent ultrasonography to the initial abnormal sonography and defining the rate of resolution.
• To assess the effect of serial transvaginal ultrasonography on the discovery of early stage disease regionally and state-wide and to determine if improvements in disease specific mortality occur as evidenced by lower deaths due to ovarian cancer in regions where screening participation is highest.
• To assess the cost-effectiveness of ovarian screening and to examine risk of medical complications arising in the screening program.
• To examine perceptions of well-being due to participation in ovarian cancer screening.
• To determine the co-factors that contribute to successful annual ultrasound screening for ovarian cancer in a asymptomatic population

 

Professional Activities:

• Department of Obstetrics & Gynecology (1985-2008)
  University of Kentucky Medical Center, Lexington Kentucky
  Research Associate Professor
• Director of Graduate Studies & Member of the Graduate College
• Director of Research Gynecologic Oncology.
• Managing Director Ovarian Cancer Screening Program
• Program Director, Forum for Reproductive Sciences (1981-1983)
• University of Kentucky Medical Center, Lexington Kentucky (1985-1990)
  Joint Assistant Professor, Department of Biochemistry
  Associate academic appointment
• Department of Obstetrics & Gynecology (1980-2011)
  University of Kentucky Medical Center, Lexington Kentucky

Post-Doctoral Appointments

• Research Associate, Department of Physiology and Biophysics.
• NCI Public Health Service Fellowship Awardee (1F32 CA06149-01)
• Visiting Assistant Professor, Department of Physiology and Biophysics
• Postdoctoral Trainee in Reproductive Biology
• Research Sponsor: Dr. Benita S. Katzenellenbogen

Academic Appointments

• Department of Obstetrics & Gynecology, University of Kentucky Medical Center, Lexington Kentucky (1980-2011)

 

Honors and Awards

Awards and Honors n

• Keynote speaker --- 4th Annual Advances in Gynaecological Oncology, The Royal Prince Albert Hospital & the Sydney Gynaecologic Oncology Group, Sydney AU, October 19, 2007.

 

Publications

1. Lefringhouse, J.R.;Neward, E.;Ueland, F.R.;Baldwin, L.A.;Miller, R.W.;Desimone, C.P.;Kryscio, R.J.;Van Nagell, J.R.;Pavlik, E.J. "Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women." Women's health (London, England) 12, 3 (2016): 303-11.
2. Ormsby, E.L.;Pavlik, E.J.;Van Nagell, J.R. "Ultrasound follow up of an adnexal mass has the potential to save lives." American journal of obstetrics and gynecology 213, 5 (2015): 657-61, 657.e1.
3. Pavlik, E.J.;Ore, R.;Toyama, A.;Woolum, D.;Pavlik, T.E.;Baldwin, L. "First year participation in the affordable care act: costs and accessibility to gynecologic oncology." Women's health (London, England) 11, 6 (2015): 865-82.
4. Elder, J.W.;Pavlik, E.J.;Long, A.;Miller, R.W.;Desimone, C.P.;Hoff, J.T.;Ueland, W.R.;Kryscio, R.J.;Nagell JR, J.;Ueland, F.R. "Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index." Gynecologic oncology 135, 1 (2014): 8-12.
5. Pavlik, E.J.;Hoff, J.;Woolum, D.;Liang, Y.;Wijers, C.;Schwartz, M.;Lefringhouse, J.;Baldwin, L. "Metrics of the gynecologic oncology literature focused on cited utilization and costs." Gynecologic oncology 132, 2 (2014): 423-7.
6. Hoff, J.;Baldwin, L.;Lefringhouse, J.;Pavlik, E.;Miller, R.;Simone, C.;Ueland, F.;Tucker, T.;Kryscio, R.;Van Nagell, J.R. "Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer." Journal of oncology 2014, (2014):312193.
7. Pavlik, E.J.;Nagell JR, J. "Early detection of ovarian tumors using ultrasound." Women's health (London, England) 9, 1 (2013): 39-55; quiz 56-7.
8. Pavlik, E.J.;Ueland, F.R.;Miller, R.W.;Ubellacker, J.M.;Desimone, C.P.;Elder, J.;Hoff, J.;Baldwin, L.;Kryscio, R.J.;Nagell JR, J. "Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography." Obstetrics and gynecology 122, 2 Pt 1 (2013): 210-7.
9. Pavlik, E.J.;Nagell JR, J. "Ovarian cancer screening--what women want." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 22 Suppl 1, (2012): S21-3.
10. Nagell JR, J.;Pavlik, E.J. "Ovarian cancer screening." Clinical obstetrics and gynecology 55, 1 (2012): 43-51.
11. Floyd, A.;Steffens, R.F.;Pavlik, E.;Andrykowski, M.A. "Receipt of a false positive test result during routine screening for ovarian cancer: a teachable moment?" Journal of clinical psychology in medical settings 18, 1 (2011): 70-7.
12. Nagell JR, J.;Miller, R.W.;Desimone, C.P.;Ueland, F.R.;Podzielinski, I.;Goodrich, S.T.;Elder, J.W.;Huang, B.;Kryscio, R.J.;Pavlik, E.J. "Longterm survival of women with epithelial ovarian cancer detected by ultrasonographic screening." Obstetrics and gynecology 118, 6 (2011): 1212-21.
13. Andrykowski, M.A.;Pavlik, E.J. "Response to an abnormal ovarian cancer-screening test result: test of the social cognitive processing and cognitive social health information processing models." Psychology & health 26, 4 (2011): 383-97.
14. Saunders, B.A.;Podzielinski, I.;Ware, R.A.;Goodrich, S.;Desimone, C.P.;Ueland, F.R.;Seamon, L.;Ubellacker, J.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "Risk of malignancy in sonographically confirmed septated cystic ovarian tumors." Gynecologic oncology 118, 3 (2010): 278-82.
15. McDonald, J.M.;Doran, S.;Desimone, C.P.;Ueland, F.R.;DePriest, P.D.;Ware, R.A.;Saunders, B.A.;Pavlik, E.J.;Goodrich, S.;Kryscio, R.J.;Nagell JR, J. "Predicting risk of malignancy in adnexal masses." Obstetrics and gynecology 115, 4 (2010): 687-94.
16. Pavlik, E.J.;Saunders, B.A.;Doran, S.;McHugh, K.W.;Ueland, F.R.;Desimone, C.P.;DePriest, P.D.;Ware, R.A.;Kryscio, R.J.;Nagell JR, J. "The
17. search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy." Cancer 115, 16 (2009):3689-98.
18. Nagell JR, J.;DePriest, P.D.;Ueland, F.R.;Desimone, C.P.;Cooper, A.L.;McDonald, J.M.;Pavlik, E.J.;Kryscio, R.J. "Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened." Cancer 109, 9 (2007): 1887-96.
19. Lykins, E.L.;Pavlik, E.L.;Andrykowski, M.A. "Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16, 3 (2007): 490-3.
20. Andrykowski, M.A.;Zhang, M.;Pavlik, E.J.;Kryscio, R.J. "Factors associated with return for routine annual screening in an ovarian cancer screening program." Gynecologic oncology 104, 3 (2007): 695-701.
21. Dietrich CS, 3rd;Desimone, C.P.;Modesitt, S.C.;DePriest, P.D.;Ueland, F.R.;Pavlik, E.J.;Kryscio, R.;Cibull, M.;Huh, W.;Partridge, E.;Numnum, T.M.;Schilder, J.;Higgins, R.V.;Nagell JR, 2nd "Primary appendiceal cancer: gynecologic manifestations and treatment options." Gynecologic oncology 104, 3 (2007): 602-6.
22. Desimone, C.P.;Van Ness, J.S.;Cooper, A.L.;Modesitt, S.C.;DePriest, P.D.;Ueland, F.R.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus." Gynecologic oncology 104, 2 (2007): 390-5.
23. Ryan, P.Y.;Graves, K.D.;Pavlik, E.J.;Andrykowski, M.A. "Abnormal ovarian cancer screening test result: women's informational, psychological and practical needs." Journal of psychosocial oncology 25, 4 (2007): 1-18.
24. Gaugler, J.E.;Pavlik, E.;Salsman, J.M.;Andrykowski, M.A. "Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test." Preventive medicine 42, 6 (2006): 463-70.
25. Ueland, F.R.;DePriest, P.D.;Desimone, C.P.;Pavlik, E.J.;Lele, S.M.;Kryscio, R.J.;Nagell JR, J. "The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size." Gynecologic oncology 99, 2 (2005): 400-3.
26. Dietrich CS, 3rd;Modesitt, S.C.;DePriest, P.D.;Ueland, F.R.;Wilder, J.;Reedy, M.B.;Pavlik, E.J.;Kryscio, R.;Cibull, M.;Giesler, J.;Manahan, K.;Huh, W.;Cohn, D.;Powell, M.;Slomovitz, B.;Higgins, R.V.;Merritt, W.;Hunter, J.;Puls, L.;Gehrig, P.;Nagell JR, J. "The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC)." Gynecologic oncology 99, 3 (2005): 557-63.
27. Andrykowski, M.A.;Boerner, L.M.;Salsman, J.M.;Pavlik, E. "Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study." Health psychology : official journal of the Division of Health Psychology, American Psychological Association 23, 6 (2004): 622-30.
28. Salsman, J.M.;Pavlik, E.;Boerner, L.M.;Andrykowski, M.A. "Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer." Preventive medicine 39, 2 (2004): 315-22
29. Modesitt, S.C.;Pavlik, E.J.;Ueland, F.R.;DePriest, P.D.;Kryscio, R.J.;Nagell JR, J. "Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter." Obstetrics and gynecology 102, 3 (2003): 594-9.
30. Ueland, F.R.;DePriest, P.D.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography." Gynecologic oncology 91, 1 (2003): 46-50.
31. Wilder, J.L.;Pavlik, E.;Straughn, J.M.;Kirby, T.;Higgins, R.V.;DePriest, P.D.;Ueland, F.R.;Kryscio, R.J.;Whitley, R.J.;Nagell, J. "Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation."Gynecologic oncology 89, 2 (2003): 233-5.
32. Pavlik, E.J.;Liu, C.;DePriest, P.D.;Gallion, H.H.;Ueland, F.R.;Kryscio, R.J.;Nagell JR, J. "Relating ovarian size to age, menopausal status, and use of hormones." Gynecologic oncology 80, 2 (2001): 333-4.
33. Pavlik, E.J.;Johnson TL, 2nd;DePriest, P.D.;Andrykowski, M.A.;Kryscio, R.J.;Nagell JR, J. "Continuing participation supports ultrasound screening for ovarian cancer." Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 15, 5 (2000): 354-64.
34. Pavlik, E.J.;DePriest, P.D.;Gallion, H.H.;Ueland, F.R.;Reedy, M.B.;Kryscio, R.J.;Nagell JR, J. "Ovarian volume related to age." Gynecologic oncology 77, 3 (2000): 410-2.
35. Nagell JR, J.;DePriest, P.D.;Reedy, M.B.;Gallion, H.H.;Ueland, F.R.;Pavlik, E.J.;Kryscio, R.J. "The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer." Gynecologic oncology 77, 3 (2000): 350-6.
36. DePriest, P.D.;Gallion, H.H.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "Transvaginal sonography as a screening method for the detection of early ovarian cancer." Gynecologic oncology 65, 3 (1997): 408-14.
37. Pavlik, E.J.;Nelson, K.;DePriest, P.D. "Publication-quality labeling of gels using transparency-mounted photographs and word processing software." BioTechniques 21, 6 (1996): 1126-7.  Nagell JR, J.;Gallion, H.H.;Pavlik, E.J.;DePriest, P.D. "Ovarian cancer screening." Cancer 76, 10 Suppl (1995): 2086-91
38. Pavlik, E.J.;Nagell JR, J.;DePriest, P.D.;Wheeler, L.;Tatman, J.M.;Boone, M.;Sollars, S.;Rayens, M.K.;Kryscio, R.K. "Participation in transvaginal ovarian cancer screening: compliance, correlation factors, and costs." Gynecologic oncology 57, 3 (1995): 395-400.
39. DePriest, P.D.;Shenson, D.;Fried, A.;Hunter, J.E.;Andrews, S.J.;Gallion, H.H.;Pavlik, E.J.;Kryscio, R.J.;Nagell JR, J. "A morphology index based on sonographic findings in ovarian cancer." Gynecologic oncology 51, 1 (1993): 7-11.
40. DePriest, P.D.;Nagell JR, J.;Gallion, H.H.;Shenson, D.;Hunter, J.E.;Andrews, S.J.;Powell, D.E.;Pavlik, E.J. "Ovarian cancer screening in asymptomatic postmenopausal women." Gynecologic oncology 51, 2 (1993): 205-9.
41. Puls, L.E.;Davey, D.D.;DePriest, P.D.;Gallion, H.H.;Nagell JR, J.;Hunter, J.E.;Pavlik, E.J. "Immunohistochemical staining for CA-125 in fallopian tube carcinomas." Gynecologic oncology 48, 3 (1993): 360-3.
42. Nagell JR, J.;DePriest, P.D.;Gallion, H.H.;Pavlik, E.J. "Ovarian cancer screening." Cancer 71, 4 Suppl (1993): 1523-8. 
43. Kenady, D.E.;Pavlik, E.J.;Nelson, K.;Van Nagell, J.R.;Gallion, H.;DePriest, P.D.;Ryo, U.Y.;Baranczuk, R.J. "Images of estrogen-receptorpositive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha." Archives of surgery (Chicago, Ill. : 1960) 128, 12 (1993): 1373-81.
44. Pavlik, E.J.;Nelson, K.;Srinivasan, S.;Powell, D.E.;Kenady, D.E.;DePriest, P.D.;Gallion, H.H.;Nagell JR, J. "Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity." Cancer research 52, 15 (1992): 4106- 12.
45. Pavlik, E.J.;Nelson, K.;Nagell JR, J.;Gallion, H.S.;Donaldson, E.S.;DePriest, P.;Meares, K.;Nagell JR, 3rd "The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation." Gynecologic oncology 42, 3 (1991): 245-9.
46. Nagell JR, J.;DePriest, P.D.;Puls, L.E.;Donaldson, E.S.;Gallion, H.H.;Pavlik, E.J.;Powell, D.E.;Kryscio, R.J. "Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography." Cancer 68, 3 (1991): 458-62.
47. Higgins, R.V.;Nagell JR, J.;Donaldson, E.S.;Gallion, H.H.;Pavlik, E.J.;Kryscio, R.J. "The efficacy of laser therapy in the treatment of cervical intraepithelial neoplasia." Gynecologic oncology 36, 1 (1990): 79-81.
48. Nagell JR, J.;Higgins, R.V.;Donaldson, E.S.;Gallion, H.H.;Powell, D.E.;Pavlik, E.J.;Woods, C.H.;Thompson, E.A. "Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened." Cancer 65, 3 (1990): 573-7.
49. Pavlik, E.J.;Nelson, K.;Gallion, H.H.;Nagell JR, J.;Donaldson, E.S.;Shih, W.J.;Spicer, J.A.;Preston, D.F.;Baranczuk, R.J.;Kenady, D.E. "Characterization of high specific activity 16 alpha-123I Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors." Cancer research 50, 24 (1990): 7799-805.
50. Higgins, R.V.;Nagell JR, J.;Donaldson, E.S.;Gallion, H.H.;Pavlik, E.J.;Endicott, B.;Woods, C.H. "Transvaginal sonography as a screening method for ovarian cancer." Gynecologic oncology 34, 3 (1989): 402-6.
51. Gallion, H.H.;Nagell JR, J.;Powell, D.F.;Donaldson, E.S.;Higgins, R.V.;Kryscio, R.J.;Pavlik, E.J.;Nelson, K. "Stage I serous papillary carcinoma of the endometrium." Cancer 63, 11 (1989): 2224-8.
52. Nelson, K.;Baranowska-Kortylewicz, J.;Nagell JR, J.;Gallion, H.H.;Donaldson, E.S.;Kenady, D.E.;McRoberts, W.P.;Pavlik, E.J. "Intermolecular engagement of estrogen receptors indicated by the formation of a high molecular weight complex during activation." Biochemistry 28, 25 (1989): 9741-9.
53. Rowley, K.C.;Gallion, H.H.;Donaldson, E.S.;Van Nagell, J.R.;Higgins, R.V.;Powell, D.E.;Kryscio, R.J.;Pavlik, E.J. "Prognostic factors in early vulvar cancer." Gynecologic oncology 31, 1 (1988): 43-9.
54. Nagell JR, J.;Powell, D.E.;Gallion, H.H.;Elliott, D.G.;Donaldson, E.S.;Carpenter, A.E.;Higgins, R.V.;Kryscio, R.;Pavlik, E.J. "Small cell carcinoma of the uterine cervix." Cancer 62, 8 (1988): 1586-93.
55. Nelson, K.;Van Nagell, J.R.;Gallion, H.;Donaldson, E.S.;Pavlik, E.J. "Estrogens and antiestrogens mediate contrasting transitions in estrogen receptor conformation which determine chromatin access: a review and synthesis of recent observations." Progress in clinical and biological research 262, (1988): 85-104.
56. Baranowska-Kortylewicz, J.;Nelson, K.;Pavlik, E.J.;Nagell JR, J.;Gallion, H.H.;Donaldson, E.S.;Kenady, D.E. "Identification of a very large nuclear estrogen receptor complex." Endocrinology 120, 5 (1987): 2189-91.
57. Cibull, M.L.;Thompson, M.E.;Smith, L.;Jennings, C.D.;Doukas, M.A.;Pavlik, E.J.;Powell, D.E. "Marked hypodiploidy in blast phase chronic myelogenous leukemia: report of a case and review of the literature." American journal of hematology 24, 3 (1987): 293-9.
58. Pavlik, E.J.;Nelson, K.;Nagell JR, J.;Donaldson, E.S.;Walden, M.L.;Gallion, H.;Kenady, D.E. "Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to 3H estradiol or 3H 4-hydroxytamoxifen." Endocrinology 120, 4 (1987): 1608-14. 
59. Flanigan, R.C.;Pavlik, E.J.;Van Nagell, J.R.;Keaton, K.;Kenady, D.E. "Proliferation, esterase activity, and propidium iodide exclusion in urologic tumor cells after in vitro exposure to chemotherapeutic agents." The Journal of urology 135, 5 (1986): 1091-100.
60. Pavlik, E.J.;Nagell JR, J.;Nelson, K.;Gallion, H.;Donaldson, E.S.;Kenady, D.E.;Baranowska-Kortylewicz, J. "Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction." Endocrinology 118, 5 (1986): 1924-34.
61. Pavlik, E.J.;Flanigan, R.C.;Bartmas, J.;Nagell JR, J.;Donaldson, E.S.;Hanson, M.B.;Gallion, H.;Kenady, D.E. "Programming for the DNA analysis of FCM data on an IBM microcomputer." Cytometry 7, 1 (1986): 93-7.
62. Pavlik, E.J.;Nelson, K.;Gallion, H.;Nagell JR, J.;Pursell, S.;Donaldson, E.S.;Flanigan, R.C.;Kenady, D.E. "The effects of acute administration of cytotoxic anticancer agents on the capacity for subsequent hormonal responses in the mouse uterus." Journal of steroid biochemistry 25, 2 (1986): 231-7.
63. Flanigan, R.C.;Pavlik, E.J.;Nagell JR, J.;Keaton, K.;Ragland, A.;Kenady, D.E. "Growth of urinary transitional cell carcinoma cell lines in agar, agarose and methyl cellulose." The Journal of urology 134, 5 (1985): 985-90.
64. Pavlik, E.J.;Nelson, K.;Nagell JR, J.;Donaldson, E.S.;Walden, M.L.;Hanson, M.B.;Gallion, H.;Flanigan, R.C.;Kenady, D.E. "Hydrodynamic characterizations of estrogen receptors complexed with 3H -4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands." Biochemistry 24, 27 (1985): 8101-6.
65. Hanson, M.B.;Nagell JR, J.;Powell, D.E.;Donaldson, E.S.;Gallion, H.;Merhige, M.;Pavlik, E.J. "The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer." Cancer 55, 8 (1985): 1753-7.
66. Pavlik, E.J.;Nelson, K.;Nagell JR, J.;Robinson, J.C.;Hanson, M.B.;Donaldson, E.S.;Flanigan, R.C.;Kenady, D.E. "Steroid receptor analysis by size-exclusion liquid chromatography: considerations for the clinical laboratory." Clinical chemistry 31, 4 (1985): 537-45. 
67. Pavlik, E.J.;Flanigan, R.C.;Nagell JR, J.;Hanson, M.B.;Donaldson, E.S.;Keaton, K.;Doss, B.;Bartmas, J.;Kenady, D.E. "Esterase activity, exclusion of propidium iodide, and proliferation in tumor cells exposed to anticancer agents: phenomena relevant to chemosensitivity determinations." Cancer investigation 3, 5 (1985): 413-26.
68. Casper, S.;Nagell JR, J.;Powell, D.F.;Dubilier, L.D.;Donaldson, E.S.;Hanson, M.B.;Pavlik, E.J. "Immunohistochemical localization of tumor markers in epithelial ovarian cancer." American journal of obstetrics and gynecology 149, 2 (1984): 154-8.
69. Nelson, K.;Pavlik, E.J.;Nagell JR, J.;Hanson, M.B.;Donaldson, E.S.;Flanigan, R.C. "Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptors." Biochemistry 23, 12 (1984): 2565-72.
70. Pavlik, E.J.;Nelson, K.;Nagell JR, J.;Christian, J.;Hanson, M.B.;Bartmas, J.;Donaldson, E.S.;Kenady, D.E. "VisiCalc and VisiPlot software routines and the analysis of data routinely encountered in steroid biochemistry." Steroids 43, 4 (1984): 393-405.
71. Pavlik, E.J.;Kenady, D.E.;Nagell JR, J.;Hanson, M.B.;Donaldson, E.S.;Casper, S.;Garrett, D.;Smith, D.;Keaton, K.;Flanigan, R.C. "Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activity." Cancer investigation 2, 6 (1984): 449-58.
72. Pavlik, E.J.;Flanigan, R.C.;Nagell JR, J.;Swanson, L.;Keaton, K.;Kenady, D.E. "The effect of different agars, agaroses and methyl cellulose on the in vitro proliferation of a human urinary transitional cell carcinoma cell line." The Journal of urology 129, 6 (1983): 1254-7.
73. Pavlik, E.J.;Kenady, D.E.;Van Nagell, J.R.;Keaton, K.;Donaldson, E.S.;Hanson, M.B.;Flanigan, R.C. "The proliferation of human tumor cell lines in the presence of different agars, agaroses, and methyl cellulose." In vitro 19, 7 (1983): 538-50.
74. Pavlik, E.J.;Kenady, D.E.;Van Nagell, J.R.;Keaton, K.;Hanson, M.B.;Donaldson, E.S.;Griffen, W.O.;Flanigan, R.C. "Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity." Cancer chemotherapy and pharmacology 11, 1 (1983): 8-15.
75. Pavlik, E.J.;Nagell JR, J.;Hanson, M.B.;Donaldson, E.S.;Powell, D.E.;Kenady, D.E. "Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line." Gynecologic oncology 14, 2 (1982): 243-61. 
76. Pavlik, E.J.;Nagell JR, J.;Donaldson, E.;Hanson, M. "Some practical aspects of the separation of estrogen and progesterone receptors by size exclusion high performance liquid chromatography which are relevant to quantitation." Journal of steroid biochemistry 17, 5 (1982): 553-8.
77. Pavlik, E.J.;Nagell JR, J.;Muncey, M.;Donaldson, E.S.;Hanson, M.;Kenady, D.;Rees, E.D.;Talwalkar, V.R. "Rapid analysis of estrogen and progesterone receptors using gel-exclusion high-performance liquid chromatography." Biochemistry 21, 1 (1982): 139-45.
78. Pavlik, E.J.;Katzenellenbogen, B.S. "The intranuclear distribution of rat uterine estrogen receptors determined after nuclease treatment and chromatin fractionation." Molecular and cellular endocrinology 26, 1-2 (1982): 201-16.
79. Katzenellenbogen, B.S.;Pavlik, E.J.;Robertson, D.W.;Katzenellenbogen, J.A. "Interaction of a high affinity anti-estrogen (alpha- 4-pyrrolidinoethoxy phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptors." The Journal of biological chemistry 256, 6 (1981): 2908-15.
80. Nagell JR, J.;Donaldson, E.S.;Hanson, M.B.;Gay, E.C.;Pavlik, E.J. "Biochemical markers in the plasma and tumors of patients with gynecologic malignancies." Cancer 48, 2 Suppl (1981): 495-503.
81. Pavlik, E.J.;Katzenellenbogen, B.S. "The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens." Molecular pharmacology 18, 3 (1980): 406-12.
82. Pavlik, E.J.;Rutledge, S. "Estrogen-binding properties of cytoplasmic and nuclear estrogen receptors in the presence of Triton X-100." Journal of steroid biochemistry 13, 12 (1980): 1433-41.
83. Pavlik, E.J.;Rutledge, S.;Eckert, R.L.;Katzenellenbogen, B.S. "Localization of estrogen receptors in uterine cells. An appraisal of translocation." Experimental cell research 123, 1 (1979): 177-89.
84. Pavlik, E.J.;Katzenellenbogen, B.S. "Human endometrial cells in primary tissue culture: estrogen interactions and modulation of cell proliferation." The Journal of clinical endocrinology and metabolism 47, 2 (1978): 333-44.
85. Coulson, P.B.;Pavlik, E.J. "Effects of estrogen and progesterone on cytoplasmic estrogen receptor and rates of protein synthesis in rat uterus." Journal of steroid biochemistry 8, 3 (1977): 205-12.
86. Pavlik, E.J.;Coulson, P.B. "Modulation of estrogen receptors in four different target tissues: differential effects of estrogen vs progesterone." Journal of steroid biochemistry 7, 5 (1976): 369-76.
87. Pavlik, E.J.;Coulson, P.B. "Hydroxylapatite "batch" assay for estrogen receptors: increased sensitivity over present receptor assays." Journal of steroid biochemistry 7, 5 (1976): 357-68.